Enzo Biochem, headquartered in Farmingdale, has agreed to sell the assets of its clinical laboratory division to Labcorp, headquartered in Burlington, North Carolina. Enzo is selling the division for ...

Enzo ended the first quarter with aggregate cash and cash equivalents of $47.7 million. The net cash used in operating activities during the first quarter decreased by $4.4 million compared to the ...

Enzo Biochem reports improved Q2 financials with increased revenue, gross margin, and operating profit, despite year-over-year revenue decline. Enzo Biochem, Inc. announced its financial results for ...

The Company's fourth-quarter revenue of $7.5 million declined year-over-year by 16%. This is due to a shift in ordering patterns. The Company’s fourth-quarter gross margin was 43%. The prior year ...

Enzo Biochem Inc. shares surged Monday after the company said a federal court judge upheld a ruling in Enzo’s favor in a patent infringement lawsuit. THE SPARK: The jury in the case awarded Enzo $48.6 ...

Enzo Biochem is a pioneer in molecular diagnostics, leading the convergence of clinical laboratories, life sciences and intellectual property through the development of unique diagnostic platform ...

NEW YORK, NY, Aug. 03, 2022 (GLOBE NEWSWIRE) -- Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo” or the “Company”), a leading biosciences and diagnostics company, today announced the addition of Matthew ...

Enzo Biochem Inc., a manufacturer of clinical products and a provider of laboratory services in East Farmingdale, will receive $2.8 million in tax abatements over 15 years to expand its operations to ...

Medical laboratory Enzo Biochem will lay off 247 employees at its Farmingdale facility in July, according to filings with the New York State Department of Labor. The layoffs come after the company ...

Enzo Biochem Inc (NYSE:ENZ) shares are soaring in extended trading Thursday after the company agreed to sell its clinical lab to Laboratory Corporation Of America (NYSE:LH). What Happened: Enzo ...

NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ), an integrated diagnostic and therapeutics company, announced today that, as part of implementing its growth strategy, it has entered into an ...